[go: up one dir, main page]

WO1993011158A3 - Peptides non-a, non-b - Google Patents

Peptides non-a, non-b Download PDF

Info

Publication number
WO1993011158A3
WO1993011158A3 PCT/EP1992/002802 EP9202802W WO9311158A3 WO 1993011158 A3 WO1993011158 A3 WO 1993011158A3 EP 9202802 W EP9202802 W EP 9202802W WO 9311158 A3 WO9311158 A3 WO 9311158A3
Authority
WO
WIPO (PCT)
Prior art keywords
nanbh
peptides
detection
applying
antibodies directed
Prior art date
Application number
PCT/EP1992/002802
Other languages
English (en)
Other versions
WO1993011158A2 (fr
Inventor
Winand Johannes Antoniu Habets
Jan Albert Hellings
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of WO1993011158A2 publication Critical patent/WO1993011158A2/fr
Publication of WO1993011158A3 publication Critical patent/WO1993011158A3/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/24011Flaviviridae
    • C12N2770/24211Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Peptides aptes à réagir de manière immunochimique avec des anticorps dirigés contre NANBH. On décrit également un procédé de détection de NANBH ou d'anti-NANBH dans un fluide testé, ainsi que des réactifs immunochimiques et un kit d'essai utilisés lors de la mise en ÷uvre de ces procédés de détection.
PCT/EP1992/002802 1991-12-06 1992-12-03 Peptides non-a, non-b WO1993011158A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP91203199 1991-12-06
NL91203199.4 1991-12-06

Publications (2)

Publication Number Publication Date
WO1993011158A2 WO1993011158A2 (fr) 1993-06-10
WO1993011158A3 true WO1993011158A3 (fr) 1993-07-08

Family

ID=8208052

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1992/002802 WO1993011158A2 (fr) 1991-12-06 1992-12-03 Peptides non-a, non-b

Country Status (1)

Country Link
WO (1) WO1993011158A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1053196C (zh) * 1992-07-16 2000-06-07 株式会社先端生命科学研究所 用于丙型肝炎病毒分类的抗原肽, 含有所述肽的药盒及用所述肽进行分类的方法
FR2775690B1 (fr) * 1998-03-09 2001-12-14 Bio Merieux Anticorps monoclonal et utilisations pour detecter des antigenes de la proteine core de vhc
EA009782B1 (ru) * 2003-09-22 2008-04-28 Грин Пептайд Ко., Лтд. Пептид, происходящий из вируса гепатита с

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0388232A1 (fr) * 1989-03-17 1990-09-19 Chiron Corporation Diagnostics et vaccins de NANBV
EP0442394A2 (fr) * 1990-02-16 1991-08-21 United Biomedical, Inc. Peptides synthétiques spécifiques pour la détection d'anticorps contre HVC, diagnostic des infections par HVC et prévention de celles-ci comme vaccins
EP0451891A2 (fr) * 1990-03-30 1991-10-16 Akzo Nobel N.V. Peptides immunochimiquement réactifs avec des anticorps contre le virus de l'hépatite non A, non B
WO1991015516A2 (fr) * 1990-04-06 1991-10-17 Genelabs Incorporated Epitopes du virus de l'hepatite c
EP0484787A2 (fr) * 1990-11-03 1992-05-13 BEHRINGWERKE Aktiengesellschaft Peptides spécifiques pour HCV, procédé pour les synthétiser et leur emploi
EP0507615A1 (fr) * 1991-04-05 1992-10-07 Biochem Pharma Inc. Peptides et mélanges de ceux-ci pour le dépistage d'anticorps contre le virus d'Hépatite C

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0388232A1 (fr) * 1989-03-17 1990-09-19 Chiron Corporation Diagnostics et vaccins de NANBV
EP0442394A2 (fr) * 1990-02-16 1991-08-21 United Biomedical, Inc. Peptides synthétiques spécifiques pour la détection d'anticorps contre HVC, diagnostic des infections par HVC et prévention de celles-ci comme vaccins
EP0451891A2 (fr) * 1990-03-30 1991-10-16 Akzo Nobel N.V. Peptides immunochimiquement réactifs avec des anticorps contre le virus de l'hépatite non A, non B
WO1991015516A2 (fr) * 1990-04-06 1991-10-17 Genelabs Incorporated Epitopes du virus de l'hepatite c
EP0484787A2 (fr) * 1990-11-03 1992-05-13 BEHRINGWERKE Aktiengesellschaft Peptides spécifiques pour HCV, procédé pour les synthétiser et leur emploi
EP0507615A1 (fr) * 1991-04-05 1992-10-07 Biochem Pharma Inc. Peptides et mélanges de ceux-ci pour le dépistage d'anticorps contre le virus d'Hépatite C

Also Published As

Publication number Publication date
WO1993011158A2 (fr) 1993-06-10

Similar Documents

Publication Publication Date Title
IL109387A0 (en) A composition for treating lesions and a detection kit for detecting lesions, containing a protein conjugate, and methods for the use thereof
CA2054798A1 (fr) Peptides specifique du vhc, leurs agents et leur utilisation
EP1318401A3 (fr) Méthode pour la détection précoce de la séroconversion d'un anticorps contre l'hépatite C virus
AU664063B2 (en) CENP-B epitope
AU6960694A (en) Endometrial proteins, antigenic compositions and methods for detecting endometriosis
ZA976196B (en) Peptide reagent for the detection of human cytomegalovirus (cmv)
HUP9800225A3 (en) Process and compounds for use in detecting analytes by measurement of residual magnetism, and the use of the said compounds
WO1993011158A3 (fr) Peptides non-a, non-b
EP0710294A4 (fr) Peptides lineaires et ramifies efficaces dans le diagnostic et la detection de l'hepatite non-a non-b
AU8562391A (en) Peptides immunochemically reactive with antibodies directed against hepatitis non-a, non-b virus
AU2547995A (en) Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1, the antigen itself, and uses thereof
AU1132292A (en) Peptides immunochemically reactive with antibodies directed against hepatitis Non-A, Non-B virus
DE3267565D1 (en) Non-a, non-b hepatitis-associated antibody conjugate, the use thereof and detection reagent
AU1690899A (en) Method for testing crohn's disease and testing kit therefor
BR9507182B1 (pt) polipeptìdeo imunologicamente reativo, polinucleotìdeo, método e kit para detecção da presença de anticorpos de t. cruzi.
EP0608117A3 (en) Antibodies for mevalonic acid and methods for determination of mevalonic acid.
CA2080408A1 (fr) Norme artificielle et serums de controle, methodes de preparation et utilisation
CA2120342A1 (fr) Peptides du virus d'epstein-barr et anticorps contre ces peptides
AU4381897A (en) New Brucella antigens, recombinant polypeptides, nucleic acids coding for the same and use thereof in diagnostic and prophylactic methods and kits
AU4294089A (en) Process for the detection of legionella antigens in body fluids and the like, as well as a test kit for performing the process
EP0870830A3 (fr) Antigene chimérique derivé du virus de l'hépatite C
AU2003260413A1 (en) Method for the detection of antibodies and/or antigens in a test liquid, particularly for determining the blood type
AU4257196A (en) New 17-kda brucella abortus antigen, recombinant polypeptides, nucleic acids coding for the same and use thereof in diagnostic and prophylactic methods and kits
WO1999006577A3 (fr) Agent permettant d'exprimer et de mettre en evidence la presence d'un polypeptide de fusion comprenant un epitope hpol et un polypeptide
KR930007970A (ko) 비-에이 형 , 비-비형 펩티드

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA FI JP KR US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA FI JP KR US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
122 Ep: pct application non-entry in european phase